Search
Monte Rosa Therapeutics Inc
GLUEAdd to Watchlist
24.020USD
-0.180-0.74%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
2.03BMarket Cap
LossP/E TTM
Monte Rosa Therapeutics Inc Earnings Date
Period
FY2025 Earnings Date
Revenue(YoY)
123.67M
63.54%
EPS(YoY)
-0.46
52.73%
Analyst Rating
BUY
2026-07-01
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Monte Rosa Therapeutics Inc?
According to Monte Rosa Therapeutics Inc's FY2025 earnings report, its total revenue reached 123.67M, with a year-on-year change of 63.54.
What are the current assets of Monte Rosa Therapeutics Inc?
According to Monte Rosa Therapeutics Inc's FY2025 earnings report, its current assets were 393.19M, with a year-on-year change of 4.17.
What are the total assets of Monte Rosa Therapeutics Inc?
According to Monte Rosa Therapeutics Inc's FY2025 earnings report, its total assets of Monte Rosa Therapeutics Inc were 448.66M, with a year-on-year change of 2.26.
What are the total liabilities of Monte Rosa Therapeutics Inc?
According to Monte Rosa Therapeutics Inc's FY2025 earnings report, its total liabilities of Monte Rosa Therapeutics Inc were 215.60M, with a year-on-year change of -0.09.
What is the total equity of Monte Rosa Therapeutics Inc?
According to Monte Rosa Therapeutics Inc's FY2025 earnings report, its total equity of Monte Rosa Therapeutics Inc was 233.06M, with a year-on-year change of 4.54.
What is the net investment of Monte Rosa Therapeutics Inc?
According to Monte Rosa Therapeutics Inc's FY2025 earnings report, its net investment of Monte Rosa Therapeutics Inc was -101.83M, with a year-on-year change of -129.09.
What is the net financing of Monte Rosa Therapeutics Inc?
According to Monte Rosa Therapeutics Inc's FY2025 earnings report, its net financing of Monte Rosa Therapeutics Inc was 30.35M, with a year-on-year change of -69.31.
What is the Earnings Per Share (EPS) of Monte Rosa Therapeutics Inc?
According to Monte Rosa Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.46, with a year-on-year change of 52.73.
What is the net margin of Monte Rosa Therapeutics Inc?
According to Monte Rosa Therapeutics Inc's FY2025 earnings report, its net profit margin was -31.23, with a year-on-year change of 67.51.
What is the Return on Equity (ROE) of Monte Rosa Therapeutics Inc?
According to Monte Rosa Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -16.94, with a year-on-year change of 53.14.
What is the Return on Assets (ROA) of Monte Rosa Therapeutics Inc?
According to Monte Rosa Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -8.71, with a year-on-year change of 55.55.
What is the operating profit of Monte Rosa Therapeutics Inc?
According to Monte Rosa Therapeutics Inc's FY2025 earnings report, its operating profit was -54.21M, with a year-on-year change of 33.17.